In response, the company has released a press statement describing the allegations as "preposterous" and stating that they acted in good faith. Aondoakka, who had allegedly demanded bribes from Pfizer in return for a settlement of the case, was declared unfit for office and ...
... developing targeted therapies for types of hematological malignancies. Find out more about Maria's research. Latest news. Pfizer Receives FDA Approval for SUTENT® (... Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT® .
Email Us. If you are a Healthcare Professional or Consumer seeking medical information about our prescription products, please contact Pfizer Medical ...
Pfizer Receives FDA Approval for SUTENT® (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell ...
Our products are meant to treat an array of illnesses across a range of therapeutic areas. They are the result of our hard work and deep commitment to creating a ...
Stock analysis for Pfizer Inc (PFE:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Pfizer Inc. manufactures, markets and/or distributes more than 360 drugs in the U.S..
News about Pfizer Inc. Commentary and archival information about Pfizer Inc. from The New York Times.
Pfizer Inc. stock price, stock quotes and financial overviews from MarketWatch.